JW Pharmaceutical Corp operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares JW Pharmaceutical Corp with three other
companies in this sector in South Korea:
Dong A St Co Ltd
sales of 560.54 billion Korean Won [US$528.58 million]
(396.13 billion Korean Won [US$373.55 million]
Boryung Pharmaceutical Company Limited
(409.14 billion Korean Won [US$385.82 million]
of which 100%
JW Pharmaceutical Corp reported sales of 467.47 billion Korean Won (US$440.82 million)
December of 2016.
increase of 7.6%
versus 2015, when the company's sales were 434.35 billion Korean Won.
This was the third consecutive year of growth at JW Pharmaceutical Corp.
The sales level in 2016 was fairly close to the level five years ago: in 2011, JW Pharmaceutical Corp had sales
of 431.01 billion Korean Won.